Latest stories on BTAI
BioXcel Therapeutics Amends Credit Agreement, Extends Debt Deadline
TipRanks55 · neutralgeneral
BioXcel Therapeutics, Inc. (BTAI) files 8-K
SEC 8-K50 · neutralgeneral
BioXcel Therapeutics, Inc. (BTAI) files 8-K
SEC 8-K50 · neutralgeneral
BTAI: [144] BioXcel Therapeutics, Inc. SEC Filing
StockTitan SEC50 · neutralgeneral
BioXcel Therapeutics GAAP EPS of -$0.54 misses by $0.06, revenue of $0.21M misses by $0.17M
Seeking Alpha34 · bearishearnings